UNSPSC 51281602: Spectinomycin

This classification denotes an aminoglycoside antibiotic with the molecular formula C14H24N2O7, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 93AKI1U6QF, chemically known as 4h-pyrano(2,3-b)(1,4)benzodioxin-4-one, decahydro-4a,7,9-trihydroxy-2-methyl-6,8-bis(methylamino)- but generally known as spectinomycin, which bears US NIH Compound Identifier 2021. European Medicines Agency schedules Spectinomycin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10614MIG.

UNSPSC 51281602 Spectinomycin is a Commodity code that nominally addresses a specific antibiotic pharmaceutical product, but recent state and local procurement activity under this code shows minimal relevant purchasing. The two opportunities posted in the recent record—an Illinois Department of Public Health piggyback pharmaceutical warehouse contract for Doxycycline Hyclate and Ciprofloxacin Hydrochloride, and a Seminole County, Florida IFB for Naloxone and drug deactivation systems—are unrelated to spectinomycin itself and do not reflect active state and local demand for the antibiotic named in the code. State and local health departments and counties may source antibiotics through cooperative purchasing vehicles such as MMCAP when epidemiologic or public health needs arise, but the code shows no substantive recent activity aligned with its nominal scope.

No current open solicitations for spectinomycin or closely related products appear in the recent opportunities block. Activity under this code does not support a pursuit recommendation at this time.